Granahan Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61M | Sell |
310,992
-50,902
| -14% | -$1.41M | 0.35% | 71 |
|
|
2025
Q1 | $8.04M | Sell |
361,894
-101,216
| -22% | -$2.25M | 0.4% | 70 |
|
|
2024
Q4 | $9.16M | Sell |
463,110
-44,259
| -9% | -$875K | 0.38% | 73 |
|
|
2024
Q3 | $12.7M | Sell |
507,369
-61,366
| -11% | -$1.53M | 0.5% | 62 |
|
|
2024
Q2 | $10.6M | Sell |
568,735
-79,352
| -12% | -$1.48M | 0.42% | 76 |
|
|
2024
Q1 | $12.8M | Sell |
648,087
-74,301
| -10% | -$1.47M | 0.45% | 67 |
|
|
2023
Q4 | $12.7M | Buy |
722,388
+188,174
| +35% | +$3.3M | 0.42% | 75 |
|
|
2023
Q3 | $9.28M | Sell |
534,214
-2,215
| -0.4% | -$38.5K | 0.33% | 90 |
|
|
2023
Q2 | $7.55M | Sell |
536,429
-38,511
| -7% | -$542K | 0.23% | 106 |
|
|
2023
Q1 | $6.19M | Buy |
574,940
+70,747
| +14% | +$761K | 0.19% | 113 |
|
|
2022
Q4 | $7.55M | Sell |
504,193
-48,157
| -9% | -$721K | 0.23% | 108 |
|
|
2022
Q3 | $7.09M | Buy |
552,350
+132,355
| +32% | +$1.7M | 0.23% | 110 |
|
|
2022
Q2 | $4.07M | Sell |
419,995
-322,163
| -43% | -$3.12M | 0.14% | 133 |
|
|
2022
Q1 | $7.38M | Buy |
742,158
+142,636
| +24% | +$1.42M | 0.18% | 113 |
|
|
2021
Q4 | $7.06M | Buy |
599,522
+193,688
| +48% | +$2.28M | 0.15% | 133 |
|
|
2021
Q3 | $4.62M | Buy |
+405,834
| New | +$4.62M | 0.09% | 156 |
|